Latest Insider Transactions at Balchem Corp (BCPC)
This section provides a real-time view of insider transactions for Balchem Corp (BCPC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BALCHEM CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BALCHEM CORP's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
Jul 31
2024
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
SELL
Open market or private sale
|
Direct |
7,750
-47.58%
|
$1,395,000
$180.05 P/Share
|
Jul 31
2024
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
BUY
Exercise of conversion of derivative security
|
Direct |
7,750
+21.45%
|
$457,250
$59.68 P/Share
|
Jul 30
2024
|
William A. Backus VP & Chief Accounting Officer |
SELL
Open market or private sale
|
Indirect |
904
-87.26%
|
$160,008
$177.1 P/Share
|
Jul 30
2024
|
William A. Backus VP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,900
-23.19%
|
$698,100
$179.86 P/Share
|
Jul 30
2024
|
William A. Backus VP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,900
+30.5%
|
$327,600
$84.09 P/Share
|
Jul 27
2024
|
Hatsuki Miyata EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-10.65%
|
$110,880
$180.78 P/Share
|
May 10
2024
|
Michael Robert Sestrick SVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,929
-28.34%
|
$297,066
$154.45 P/Share
|
May 08
2024
|
David B Fischer |
SELL
Open market or private sale
|
Direct |
5,000
-18.87%
|
$765,000
$153.37 P/Share
|
Mar 08
2024
|
Michael Brent Tignor SVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
5,339
-21.84%
|
$838,223
$157.65 P/Share
|
Mar 08
2024
|
Michael Brent Tignor SVP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,200
+23.45%
|
$357,000
$85.4 P/Share
|
Mar 04
2024
|
Matthew David Wineinger |
SELL
Open market or private sale
|
Direct |
1,333
-17.79%
|
$207,948
$156.89 P/Share
|
Feb 26
2024
|
William A. Backus VP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,000
-21.15%
|
$1,085,000
$155.38 P/Share
|
Feb 23
2024
|
William A. Backus VP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
9,180
-23.22%
|
$1,432,080
$156.55 P/Share
|
Feb 23
2024
|
William A. Backus VP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,180
+18.65%
|
$725,220
$79.49 P/Share
|
Feb 22
2024
|
Theodore L Harris Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
34,350
-12.91%
|
$5,289,900
$154.49 P/Share
|
Feb 22
2024
|
Theodore L Harris Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
34,350
+15.52%
|
$1,957,950
$57.86 P/Share
|
Feb 21
2024
|
William A. Backus VP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
15,000
-18.51%
|
$2,310,000
$154.64 P/Share
|
Feb 21
2024
|
William A. Backus VP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+34.95%
|
$900,000
$60.85 P/Share
|
Feb 21
2024
|
Theodore L Harris Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
29,679
-8.54%
|
$4,570,566
$154.37 P/Share
|
Feb 21
2024
|
Michael Robert Sestrick SVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
11,100
-62.23%
|
$1,698,300
$153.21 P/Share
|
Feb 21
2024
|
Michael Robert Sestrick SVP & Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,100
+21.29%
|
$865,800
$78.52 P/Share
|
Feb 11
2024
|
Theodore L Harris Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,452
-3.47%
|
$500,540
$145.33 P/Share
|
Feb 11
2024
|
Michael Brent Tignor SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
354
-3.62%
|
$51,330
$145.33 P/Share
|
Feb 11
2024
|
Carl Martin Bengtsson EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
832
-4.04%
|
$120,640
$145.33 P/Share
|
Feb 11
2024
|
Martin Luther Reid SVP Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
325
-4.76%
|
$47,125
$145.33 P/Share
|
Feb 11
2024
|
William A. Backus VP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
751
-5.5%
|
$108,895
$145.33 P/Share
|
Feb 11
2024
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
SELL
Payment of exercise price or tax liability
|
Direct |
281
-3.19%
|
$40,745
$145.33 P/Share
|
Feb 11
2024
|
Michael Robert Sestrick SVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-4.43%
|
$45,240
$145.33 P/Share
|
Feb 11
2024
|
Jonathan Harrison Griffin SVP & GM, Animal Nutrition |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-1.7%
|
$31,900
$145.33 P/Share
|
Feb 08
2024
|
Michael Robert Sestrick SVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,104
-13.54%
|
$157,872
$143.43 P/Share
|
Feb 08
2024
|
Michael Robert Sestrick SVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,679
+14.68%
|
-
|
Feb 08
2024
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
SELL
Payment of exercise price or tax liability
|
Direct |
957
-9.79%
|
$136,851
$143.43 P/Share
|
Feb 08
2024
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
BUY
Grant, award, or other acquisition
|
Direct |
2,174
+10.17%
|
-
|
Feb 08
2024
|
Frederic Boned SVP/GM, Human Nutri. & Health |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+20.59%
|
-
|
Feb 08
2024
|
Monica Vicente |
BUY
Grant, award, or other acquisition
|
Direct |
540
+50.0%
|
-
|
Feb 08
2024
|
Olivier Rigaud |
BUY
Grant, award, or other acquisition
|
Direct |
540
+50.0%
|
-
|
Feb 08
2024
|
Michael Brent Tignor SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,244
-11.29%
|
$177,892
$143.43 P/Share
|
Feb 08
2024
|
Michael Brent Tignor SVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,004
+12.6%
|
-
|
Feb 08
2024
|
Martin Luther Reid SVP Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,688
-10.42%
|
$241,384
$143.43 P/Share
|
Feb 08
2024
|
Martin Luther Reid SVP Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,113
+21.29%
|
-
|
Feb 08
2024
|
Hatsuki Miyata EVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+17.01%
|
-
|
Feb 08
2024
|
Joyce J. Lee |
BUY
Grant, award, or other acquisition
|
Direct |
540
+16.28%
|
-
|
Feb 08
2024
|
Daniel E Knutson |
BUY
Grant, award, or other acquisition
|
Direct |
540
+9.66%
|
-
|
Feb 08
2024
|
Theodore L Harris Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,768
-10.57%
|
$1,682,824
$143.43 P/Share
|
Feb 08
2024
|
Theodore L Harris Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
27,289
+11.24%
|
-
|
Feb 08
2024
|
Jonathan Harrison Griffin SVP & GM, Animal Nutrition |
SELL
Payment of exercise price or tax liability
|
Direct |
793
-5.77%
|
$113,399
$143.43 P/Share
|
Feb 08
2024
|
Jonathan Harrison Griffin SVP & GM, Animal Nutrition |
BUY
Grant, award, or other acquisition
|
Direct |
3,110
+10.38%
|
-
|
Feb 08
2024
|
Kathleen B Fish |
BUY
Grant, award, or other acquisition
|
Direct |
540
+25.48%
|
-
|
Feb 08
2024
|
Carl Martin Bengtsson EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,868
-12.23%
|
$410,124
$143.43 P/Share
|
Feb 08
2024
|
Carl Martin Bengtsson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,065
+13.84%
|
-
|